Recombinant Human NEDD8 Protein，His

NEDD8 (Neural Precursor Cell-Expressed Developmentally Downregulated 8) is a small ubiquitin-like protein that plays a crucial role in regulating various cellular processes, including cell-cycle progression, signal transduction, and protein degradation. Research into NEDD8 has gained momentum due to its involvement in the activation of cullin-RING ligases (CRLs), a family of enzymes responsible for ubiquitination and subsequent proteasomal degradation of target proteins, which is essential for maintaining cellular homeostasis. Dysregulation of NEDD8 and its associated pathways has been implicated in several diseases, including cancer, where aberrant protein turnover can lead to the accumulation of oncogenic factors or the loss of tumor suppressors. Consequently, NEDD8 has emerged as a promising target for therapeutic intervention. Studies focusing on NEDD8 modification mechanisms and its role in oncogenic signaling pathways have provided insights into its potential as a biomarker for cancer prognosis and as a target for novel drug development. The engineering and characterization of recombinant NEDD8 proteins have facilitated in vitro studies, enabling researchers to elucidate its structure-function relationships and interactions with other ubiquitin-like proteins and ligases. This foundational research lays the groundwork for developing NEDD8 inhibitors, which may offer new avenues for cancer treatment and a deeper understanding of proteostasis in both normal and diseased states. As research progresses, the therapeutic targeting of the NEDD8 pathway holds promise for the development of innovative strategies in oncology and beyond.